Abstract
Our nation's ongoing prescription opioid abuse crisis, amounting to over 78 billion dollars in health and social costs annually,1 is a critical priority for the US Food and Drug Administration (FDA). As a part of our mission to support the safe and effective use of prescription medicines, the FDA is taking a fresh look at potential scientific and regulatory actions we can take to address this crisis.
Published 2018. This article is a U.S. Government work and is in the public domain in the USA.
MeSH terms
-
Analgesics, Opioid / therapeutic use*
-
Drug Discovery / organization & administration
-
Drug and Narcotic Control / legislation & jurisprudence
-
Drug and Narcotic Control / organization & administration*
-
Humans
-
Opioid-Related Disorders / epidemiology*
-
Opioid-Related Disorders / prevention & control
-
Opioid-Related Disorders / therapy
-
Pain / drug therapy*
-
Pain Management / methods
-
Prescription Drugs / standards*
-
Risk Assessment
-
United States
-
United States Food and Drug Administration / legislation & jurisprudence
-
United States Food and Drug Administration / organization & administration*
-
United States Food and Drug Administration / standards
Substances
-
Analgesics, Opioid
-
Prescription Drugs